BML Capital Management’s Kalaris Therapeutics KLRS Stock Holding History

BML Capital Management’s Portfolio KLRS Stock Details KLRS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$77.4K	Sell
2024 Q3	$488K	Hold
2024 Q2	$436K	Buy
2024 Q1	$151K	Buy